{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:02Z","timestamp":1786987022524,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009809","name":"John T Reid Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014555","name":"Murdoch Childrens Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clnu.2021.06.008","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T17:30:13Z","timestamp":1623778213000},"page":"4702-4711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of a multicomponent nutritional supplement on functional outcomes for Duchenne muscular dystrophy: A randomized controlled trial"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-7689","authenticated-orcid":false,"given":"Zoe E.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6397-1910","authenticated-orcid":false,"given":"Monique M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3985-9472","authenticated-orcid":false,"given":"Andrew J.","family":"Kornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7123-0351","authenticated-orcid":false,"given":"Anita G.","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1268-1005","authenticated-orcid":false,"given":"Meghan","family":"Hutchence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1992-1649","authenticated-orcid":false,"given":"Helen","family":"Truby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2021.06.008_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases--a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clnu.2021.06.008_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clnu.2021.06.008_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clnu.2021.06.008_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.39.4.475","article-title":"Duchenne muscular dystrophy","volume":"39","author":"Brooke","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.clnu.2021.06.008_bib5","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1097\/00002060-199509001-00003","article-title":"Profiles of neuromuscular diseases. Duchenne muscular dystrophy","volume":"74","author":"McDonald","year":"1995","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.clnu.2021.06.008_bib6","series-title":"The metabolic and molecular bases of inherited disease","first-page":"5493","article-title":"The muscular dystrophies","author":"Worton","year":"2001"},{"key":"10.1016\/j.clnu.2021.06.008_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0887-8994(95)00251-0","article-title":"Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy","volume":"14","author":"Boland","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.clnu.2021.06.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of systemic delivery of rAAVrh74.MHCK7.micro-dystrophin in children with duchenne muscular dystrophy: a nonrandomized controlled trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clnu.2021.06.008_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: corticosteroid treatment of duchenne muscular dystrophy: report of the guideline development subcommittee of the American academy of neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clnu.2021.06.008_bib10","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2021.06.008_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clnu.2021.06.008_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-277X.2009.00979.x","article-title":"A\u00a0review of nutrition in Duchenne muscular dystrophy","volume":"22","author":"Davidson","year":"2009","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1016\/j.clnu.2021.06.008_bib13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0883073811426501","article-title":"Use of complementary and alternative medicine by males with duchenne or becker muscular dystrophy","volume":"27","author":"Nabukera","year":"2012","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.clnu.2021.06.008_bib14","series-title":"Regenerative medicine for degenerative muscle diseases","first-page":"225","article-title":"Practical nutrition guidelines for individuals with duchenne muscular dystrophy","author":"Davidson","year":"2016"},{"key":"10.1016\/j.clnu.2021.06.008_bib15","first-page":"CD004760","article-title":"Creatine for treating muscle disorders","volume":"6","author":"Kley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2021.06.008_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20436","article-title":"Nutritional therapy improves function and complements corticosteroid intervention in mdx mice","volume":"33","author":"Payne","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clnu.2021.06.008_bib17","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1096\/fj.09-134411","article-title":"Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts","volume":"23","author":"Vandenburgh","year":"2009","journal-title":"Faseb J"},{"key":"10.1016\/j.clnu.2021.06.008_bib18","doi-asserted-by":"crossref","first-page":"104917","DOI":"10.1016\/j.phrs.2020.104917","article-title":"Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks","volume":"158","author":"Boccanegra","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clnu.2021.06.008_bib19","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/mus.21808","article-title":"The 6-minute walk test in Duchenne\/Becker muscular dystrophy: longitudinal observations","volume":"42","author":"McDonald","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clnu.2021.06.008_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.21544","article-title":"The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy","volume":"41","author":"McDonald","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clnu.2021.06.008_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nmd.2008.11.004","article-title":"Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire","volume":"19","author":"Vandervelde","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clnu.2021.06.008_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/CND.0b013e3181c5053b","article-title":"The PedsQL in pediatric patients with duchenne muscular dystrophy: feasibility, reliability, and validity of the pediatric quality of life inventory neuromuscular module and generic core scales","volume":"11","author":"Davis","year":"2010","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"key":"10.1016\/j.clnu.2021.06.008_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","article-title":"The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity","volume":"3","author":"Varni","year":"2003","journal-title":"Ambul Pediatr"},{"key":"10.1016\/j.clnu.2021.06.008_bib24","series-title":"CDC growth charts: United States","author":"Kuczmarski","year":"2000"},{"key":"10.1016\/j.clnu.2021.06.008_bib25","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.apmr.2008.01.024","article-title":"A\u00a0comparison between self-reported and observed activity limitations in adults with neuromuscular disorders","volume":"89","author":"Vandervelde","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clnu.2021.06.008_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2007.02.013","article-title":"ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders","volume":"17","author":"Vandervelde","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clnu.2021.06.008_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nmd.2008.11.004","article-title":"Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire","volume":"19","author":"Vandervelde","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clnu.2021.06.008_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/0884533614546696","article-title":"Accuracy of parent-reported energy intake and physical activity levels in boys with duchenne muscular dystrophy","volume":"30","author":"Elliott","year":"2015","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2021.06.008_bib29","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.apmr.2004.10.012","article-title":"Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy","volume":"86","author":"McDonald","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clnu.2021.06.008_bib30","series-title":"Cross-over trials in clinical research","author":"Senn","year":"2002"},{"key":"10.1016\/j.clnu.2021.06.008_bib31","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/(SICI)1097-0258(19991130)18:22<3037::AID-SIM243>3.0.CO;2-7","article-title":"A\u00a0mixed effects model for the analysis of repeated measures cross-over studies","volume":"18","author":"Putt","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.clnu.2021.06.008_bib32","series-title":"Application of linear mixed-effects models to crossover designs (Electronic Theses and Dissertations)","author":"Zhou","year":"2012"},{"key":"10.1016\/j.clnu.2021.06.008_bib33","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1093\/pch\/pxy072","article-title":"Effect of music (Brahms lullaby) and non-nutritive sucking on heel lance in preterm infants: a randomized controlled crossover trial","volume":"24","author":"Uematsu","year":"2018","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.clnu.2021.06.008_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mus.23905","article-title":"The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study","volume":"48","author":"McDonald","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clnu.2021.06.008_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ana.20523","article-title":"CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy","volume":"58","author":"Escolar","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clnu.2021.06.008_bib36","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1212\/01.WNL.0000125178.18862.9D","article-title":"Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy","volume":"62","author":"Tarnopolsky","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clnu.2021.06.008_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12970-017-0173-z","article-title":"International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine","volume":"14","author":"Kreider","year":"2017","journal-title":"J\u00a0Int Soc Sports Nutr"},{"key":"10.1016\/j.clnu.2021.06.008_bib38","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/archdischild-2015-308825","article-title":"Vitamin D in corticosteroid-na\u00efve and corticosteroid-treated Duchenne muscular dystrophy: what dose achieves optimal 25(OH) vitamin D levels?","volume":"101","author":"Alshaikh","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clnu.2021.06.008_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151445","article-title":"Timed rise from floor as a predictor of disease progression in duchenne muscular dystrophy: an observational study","volume":"11","author":"Mazzone","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.clnu.2021.06.008_bib40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.nmd.2018.05.004","article-title":"Nutrition in duchenne muscular dystrophy 16-18 march 2018, zaandam, The Netherlands","volume":"28","author":"Verhaart","year":"2018","journal-title":"Neuromuscul Disord"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421002958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421002958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:02:08Z","timestamp":1759366928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561421002958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0261561421002958"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2021.06.008","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of a multicomponent nutritional supplement on functional outcomes for Duchenne muscular dystrophy: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2021.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}